$PBIO Pressure BioSciences Awarded Pivotal U.S. Pa
Post# of 40252
New Patent Secures and Protects Company's Control Over Its Best Selling PCT Sample Preparation Consumable Product, the PCT MicroPestle
SOUTH EASTON, Mass., Aug. 12, 2020 /PRNewswire/ -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company", a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform solutions to the worldwide Life Sciences and other industries, today announced the award of a key U.S. patent entitled "Sample Preparation Devices and Methods". This new patent (US 10,710,082) brings the Company's Intellectual Property ("IP" estate up to a total of 25 issued patents.
1️⃣I do not provide personal investment advice and I am not a qualified licensed investment advisor. I am an amateur investor.
2️⃣All information found here, including any ideas, opinions, views, predictions, forecasts, commentaries, suggestions, or stock picks, expressed or implied herein, are for informational, entertainment or educational purposes only and should not be construed as personal investment advice. While the information provided is believed to be accurate, it may include errors or inaccuracies.
3️⃣I will not and cannot be held liable for any actions you take as a result of anything you read here.
4️⃣Conduct your own due diligence, or consult a licensed financial advisor or broker before making any and all investment decisions. Any investments, trades, speculations, or decisions made on the basis of any information found on this site, expressed or implied herein, are committed at your own risk, financial or otherwise.